Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology
Each subsidiary may utilize the CPB platform capabilities to commercialize products independently or through strategic collaborations. The subsidiaries’ diverse product pipeline mitigates the risk associated with individual development and drive opportunities forward.
Human Microbiome
Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology
Immuno-oncology
Readout & completion of POC from first in-human study in 2024;
Initiation of phase 2 in 2025
IBD
Clinical batch production of drug candidate for IBD as preparation for Phase 1 clinical trials in USA, in 2024
IBS
Advancement of pre-clinical studies and nomination of bacterial consortium for clinical trial
Ag-Chemicals
AgPlenus Mission: Design next-generation, effective, and sustainable crop protection products by leveraging predictive chemistry and biology
Herbicides
Corteva collaboration - achieve 2nd milestone;
Bayer collaboration - design additional molecules
Fungicides
Identification of 2 selected novel targets;
Generate HITs for the selected targets
Castor Oil Production
Castera Mission: Leading the castor oil market with an integrated solution for industrialized cultivation of castor in support of the biobased materials industry
Seeds production operations
Expanding the seed production operations in several sites in Africa & Latin America, to fulfill all existing orders
Strategic alliances
Extending the collaboration frame in the biofuel space – more territories and new global partners
R&D
Developing castor varieties that meet commercially valuable traits for the Biodiesel and Sustainable Aviation Fuel (SAF) industries
Machinery
Improving mechanical harvesting solutions through collaborations with global machinery companies